Human TNFSF13/APRIL/CD256 ORF/cDNA clone-Lentivirus particle (NM_003808)

Cat. No.: vGMLP005046

Pre-made Human TNFSF13/APRIL/CD256 Lentiviral expression plasmid for TNFSF13 lentivirus packaging, TNFSF13 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.

Target products collection

Go to APRIL/TNFSF13/CD256/TNFSF13/APRIL products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name lentivirus Grade lentivirus quantity
vGMLP005046 Human TNFSF13 Lentivirus particle Pilot Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
Research Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMLP005046
Gene Name TNFSF13
Accession Number NM_003808
Gene ID 8741
Species Human
Product Type Lentivirus particle (overexpression)
Insert Length 753 bp
Gene Alias APRIL,CD256,TALL-2,TALL2,TNLG7B,TRDL-1,UNQ383/PRO715,ZTNF2
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGCCAGCCTCATCTCCTTTCTTGCTAGCCCCCAAAGGGCCTCCAGGCAACATGGGGGGCCCAGTCAGAGAGCCGGCACTCTCAGTTGCCCTCTGGTTGAGTTGGGGGGCAGCTCTGGGGGCCGTGGCTTGTGCCATGGCTCTGCTGACCCAACAAACAGAGCTGCAGAGCCTCAGGAGAGAGGTGAGCCGGCTGCAGGGGACAGGAGGCCCCTCCCAGAATGGGGAAGGGTATCCCTGGCAGAGTCTCCCGGAGCAGAGTTCCGATGCCCTGGAAGCCTGGGAGAATGGGGAGAGATCCCGGAAAAGGAGAGCAGTGCTCACCCAAAAACAGAAGAAGCAGCACTCTGTCCTGCACCTGGTTCCCATTAACGCCACCTCCAAGGATGACTCCGATGTGACAGAGGTGATGTGGCAACCAGCTCTTAGGCGTGGGAGAGGCCTACAGGCCCAAGGATATGGTGTCCGAATCCAGGATGCTGGAGTTTATCTGCTGTATAGCCAGGTCCTGTTTCAAGACGTGACTTTCACCATGGGTCAGGTGGTGTCTCGAGAAGGCCAAGGAAGGCAGGAGACTCTATTCCGATGTATAAGAAGTATGCCCTCCCACCCGGACCGGGCCTACAACAGCTGCTATAGCGCAGGTGTCTTCCATTTACACCAAGGGGATATTCTGAGTGTCATAATTCCCCGGGCAAGGGCGAAACTTAACCTCTCTCCACATGGAACCTTCCTGGGGTTTGTGAAACTGTGA
ORF Protein Sequence MPASSPFLLAPKGPPGNMGGPVREPALSVALWLSWGAALGAVACAMALLTQQTELQSLRREVSRLQGTGGPSQNGEGYPWQSLPEQSSDALEAWENGERSRKRRAVLTQKQKKQHSVLHLVPINATSKDDSDVTEVMWQPALRRGRGLQAQGYGVRIQDAGVYLLYSQVLFQDVTFTMGQVVSREGQGRQETLFRCIRSMPSHPDRAYNSCYSAGVFHLHQGDILSVIIPRARAKLNLSPHGTFLGFVKL

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Biosimilar GMP-Bios-ab-518 Pre-Made Sibeprenlimab biosimilar, Whole mAb, Anti-TNFSF13/APRIL Antibody: Anti-CD256/TALL-2/TALL2/TNLG7B/TRDL-1/UNQ383/PRO715/ZTNF2 therapeutic antibody
    Biosimilar GMP-Bios-INN-742 Pre-Made Atacicept Biosimilar, Fusion Protein targeting TNFSF13/APRIL fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting CD256/TALL-2/TALL2/TNLG7B/TRDL-1/UNQ383/PRO715/ZTNF2
    Target Antibody GM-Tg-g-T14676-Ab Anti-TNF13/ APRIL/ TNFSF13 functional antibody
    Target Antigen GM-Tg-g-T14676-Ag APRIL/TNFSF13 protein
    Cytokine cks-Tg-g-GM-T14676 tumor necrosis factor (ligand) superfamily, member 13 (TNFSF13) protein & antibody
    ORF Viral Vector pGMLP005046 Human TNFSF13 Lentivirus plasmid
    ORF Viral Vector vGMLP005046 Human TNFSF13 Lentivirus particle


    Target information

    Target ID GM-T14676
    Target Name APRIL/TNFSF13/CD256
    Gene Group Identifier
    （Target Gene ID in Homo species)         		8741
    Gene ID 100147233 (Equus caballus), 100328582 (Felis catus), 100551507 (Macaca mulatta), 100568281 (Canis lupus familiaris)
    287437 (Rattus norvegicus), 538567 (Bos taurus), 69583 (Mus musculus), 8741 (Homo sapiens)
    Gene Symbols & Synonyms TNFSF13,Tnfsf13,TNLG7B,April,Tnlg7b,APRIL,Tall2,Trdl1,2310026N09Rik,CD256,TALL2,ZTNF2,TALL-2,TRDL-1,UNQ383/PRO715
    Target Alternative Names 2310026N09Rik,A proliferation-inducing ligand (APRIL),APRIL,April,CD256,TALL-2,TALL2,TNF- and APOL-related leukocyte expressed ligand 2 (TALL-2),TNF-related death ligand 1 (TRDL-1),TNFSF13,TNLG7B,TRDL-1,Tall2,Tnfsf13,Tnlg7b,Trdl1,Tumor necrosis factor ligand superfamily member 13,UNQ383/PRO715,ZTNF2
    Uniprot Accession O75888,Q9D777
    Additional SwissProt Accessions: Q9D777,O75888
    Uniprot Entry Name
    Protein Sub-location Secreted Protein/Potential Cytokines
    Category Therapeutics Target, Immuno-oncology Target, INN Index, Cytokine Target
    Disease cancer, Lupus Glomerulonephritis
    Disease from KEGG Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Rheumatoid arthritis
    Gene Ensembl ENSECAG00000034840, ENSMMUG00000006327, ENSCAFG00845023070, ENSBTAG00000000130, ENSMUSG00000089669, ENSG00000161955
    Target Classification Checkpoint-Immuno Oncology


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.